Telegraph UK has a surreal article, gaslighting the gullible into believing the medical cartel and government care about the public enjoying good health.
used.
One person commits suicide because of a drug, and it's a major story.
and it's a suppressed story.
Also not mentioned by Telegraph is the fact that mental challenges caused by Cipro have been well-documented for more than twenty years. And are not rare at all. For example, an article from Worst Pills that was published in October, 2002, titled "Drug Induced Psychiatric Symptoms". The Worst Pills article is behind a paywall, and I'll respect that, but under the doctrine of Fair Use--and at only fifteen bucks a year, Worst Pills is a bargain--here's the pertinent part:
Family:
Fluoroquinolone Antibiotics
Examples:
ciprofloxacin (CIPRO); levofloxacin (LEVAQUIN); sparfloxacin (ZAGAM)
Reactions
psychosis, confusion, agitation, depression, hallucinations, paranoia, Tourette-like syndrome (a form of tic), mania
Notes:
many reports
Source:
https://www.worstpills.org/newsletters/view/35 ___________________________________________________________
A retired cardiologist with no history of mental health problems took his own life one week after taking an antibiotic with a “rare” link to suicide, a coroner has found.
Robert Stevenson, a “respected” and “experienced” consultant cardiologist, hanged himself around a week after he started a course of ciprofloxacin.
Coroner Martin Fleming has issued a warning over potential side-effect of the antibiotic, which is commonly used in the health service. In 2020, UK community pharmacists dispensed around one million prescriptions for ciprofloxacin, according to The Ecologist.
[Snip]
Writing to the Medicines and Healthcare products Regulatory Agency (MHRA), the coroner said doctors may not be aware of the potential side-effect.
“During the inquest, I was referred by Mr Stevenson’s treating urologist to published literature relating to ciprofloxacin and quinolone antibiotics and a potential rare link to suicidal behaviour in patients,” he said.
“Although I found on the balance of probabilities that it remained unclear that he was suffering from this side-effect, it remained possible for this to be the case. I heard evidence to suggest that the prescribing doctor did not reference this side-effect at the time of issuing the prescription to Mr Stevenson, since it was not in accord with current advice.”
[Snip]
Dr Janine Jolly, the MHRA deputy director of benefit/risk evaluation, said: “We are very sorry to hear of Dr Stevenson’s death and would like to express our sympathies to his family.”
“As with any serious suspected side-effects, reports of fatalities are evaluated by us, including an assessment of post-mortem details if available. We will be reviewing the coroner’s verdict.”
“We will carefully consider the points raised by the coroner in the Regulation 28 Report to consider whether further regulatory action is required to minimise risks to patients and will provide a response upon completion of our investigation.”